News

The AFL-CIO asked the U.S. Court of Appeals for the District of Columbia Circuit to order the Occupational Safety and Health Administration to issue within 30 days an emergency temporary standard to protect U.S. workers from COVID-19 under the Occupational Safety and Health Act of 1970.

In response to the significant impact of the COVID-19 pandemic on nursing homes, the Centers for Medicare & Medicaid Services recommended criteria for state and local officials who are considering how to mitigate risks.

The Small Business Administration released the application that borrowers must submit to the lender servicing their Paycheck Protection Program loan to request forgiveness for some or all of the loan.

The CDC awarded $10.25 billion from the Paycheck Protection Program and Health Care Enhancement Act to states, territories and local jurisdictions, and $750 million to tribal health programs to expand COVID-19 testing capacity and related activities.

HHS announced a $354 million agreement with a private partnership to make more active pharmaceutical ingredients and generic drugs in the United States to treat patients hospitalized with COVID-19 and prevent shortages of essential medicines.

The AHA, Association of periOperative Registered Nurses, and AdvaMed released clinically based guidance to support the safe reentry of medical device representatives into hospitals and other surgical facilities as they resume elective surgeries paused during the COVID-19 pandemic.

State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic.

Infectious virus in feces is a common manifestation of COVID-19, according to a study from China published in the Center for Disease Control and Prevention’s Emerging Infectious Diseases journal.

The Food and Drug Administration authorized the emergency use of Everlywell, Inc.’s COVID-19 Test Home Collection Kit.

The Trump administration introduced Operation Warp Speed, a $10 billion public-private partnership intended to accelerate development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics by January 2021.

The Department of Health and Human Services has canceled today’s deadline for hospitals and health systems to submit data to inform the agency’s distribution of its supply of remdesivir.

Our just-concluded National Hospital Week provided many great opportunities to express our heartfelt thanks to the remarkable caregivers who continue to minister to COVID-19 patients—and all patients who come through our hospital and health system doors—every day in every community across America.

The House yesterday passed the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act — a $3 trillion COVID-19 relief package.

The National Academies of Sciences Engineering, and Medicine released recommendations for improving outcomes and metrics associated with four grant programs funded by the Substance Abuse and Mental Health Services Administration to help reduce opioid-related harm and promote recovery from substance use disorder.

The Healthcare and Public Health Sector Coordinating Council, a public-private partnership developed to mitigate threats to the nation’s health care sector, released guidance and recommendations to help health care organizations protect trade secrets, medical research and other innovation capital from theft. 

Health care systems face difficult challenges in their effort to provide safe and effective care not just for COVID-19 patients, but all patients living with serious illness.

The AHA today debuted a new video that spotlights the value of membership in the AHA, including how the association is telling hospital and health systems’ stories, advocating for funding and regulatory relief, getting resources to the front lines and helping to lead the field to recovery.

Shelter-in-place orders and the closure of restaurants, bars and entertainment-related businesses helped to slow the spread of COVID-19 between March 1 and April 27, according to a study published by Health Affairs.

The Food and Drug Administration authorized the emergency use of infusion pumps to counteract insufficient supplies needed for the continuous infusion of medications, total parenteral nutrition and other fluids into COVID-19 patients.

Based on early data, the Abbott ID NOW point-of-care test to diagnose COVID-19 may return false negative results, the Food and Drug Administration announced, adding that it will continue to review data as the company conducts post-market studies to better understand the cause.